• Home

 

 

  • About Us
    • Overview
    • Message from the CEO
    • Vision & Values
    • Community Relations
    • History
    • Officers
    • Board of Directors
    • Customer Relationships
    • Business Development
  • Clinical Markets
    • Overview
    • Cardiovascular
    • Ophthalmology
    • Pharmaceuticals
    • In Vitro Diagnostics
    • Other Clinical Markets
  • Technologies
    • Overview
    • Drug Delivery
    • Surface Modification
  • Investors
    • Investor Overview
    • Officers
    • Directors
    • Stock Performance
    • Financial Highlights
    • News Releases
    • Analyst Coverage
    • Annual Reports
    • Corporate Governance
    • SEC Filings
    • Conference Calls
    • IR Events
    • Presentations
    • Investor Inquiries
  • News & Events
    • Events Calendar
    • News Releases
  • Careers
    • Overview
    • Open Positions
    • Network with SurModics
    • Company Culture
    • Benefits
    • Business Overview
  • Home
  • Contact Us
Advancing diagnostic and therapeutic applications.
  • Cardiovascular
  • Ophthalmology
  • Pharmaceuticals
  • In Vitro Diagnostics
  • Other Clinical Markets
Enabling the performance and enhancing the functionality of medical devices, drugs, and diagnostics.
  • Drug Delivery
  • Surface Modification


Recent News

SurModics Opens World-class cGMP Facility for Manufacturing and Development in Birmingham, Alabama

New Manfacturing Facility Video

SurModics and NuPathe Partner to Develop Novel Long-Acting Parkinson's Treatment

SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech

 

 

Privacy Policy | Terms of Use | © 2009 SurModics, Inc. All Rights Reserved